November 12, 2024
1 min watch
Save
VIDEO: Technology needed to measure impact of geographic atrophy treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, of Duke Eye Center in Durham, North Carolina, discusses the adoption of therapies for the treatment of geographic atrophy.
“There is a big need for identifying technologies that will not only help us identify patients who will benefit but also see the effect of the therapy we are using, whether it is truly slowing down the condition for that patient,” she said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Vajzovic reports consulting for Apellis, Astellas, Ocugen and ONL Therapeutics.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.